Boundless Bio Financials - Benzinga

Boundless Bio Inc

BOLDNASDAQ

Trade with Public

Trade with Public

$2.84

0.041.43%

At close: Aug 6, 5:00 PM EST

$2.87

0.031.06%

After Hours: 6:46 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Boundless Bio Financials

Boundless Bio (BOLD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Boundless Bio Q1 EPS $(0.60) Beats $(0.64) Estimate

Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.64) by 4.76 percent. This is a 15.49 percent increase over losses of $(0.71) per share from the

Benzinga Newsdesk

PRO
Boundless Bio Q4 EPS $(0.58) Misses $(0.52) Estimate

Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.52) by 11.54 percent. This is a 21.62 percent increase over losses of $(0.74) per share from

Benzinga Newsdesk

PRO
Boundless Bio Q3 EPS $(0.62) Misses $(0.53) Estimate

Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.53) by 16.32 percent. This is a 16.22 percent increase over losses of $(0.74) per share from

Benzinga Newsdesk

PRO
Boundless Bio Q2 EPS $(0.70) Beats $(0.71) Estimate

Benzinga Newsdesk

PRO
Boundless Bio Q1 EPS $(0.71) Beats $(0.73) Estimate

Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.73) by 2.74 percent. This is a 94.21 percent increase over losses of $(12.27) per share from the

Benzinga Newsdesk

PRO
Boundless Bio Q4 2024 GAAP EPS $(0.74) Beats $(0.77) Estimate

Benzinga Newsdesk